|Year : 2018 | Volume
| Issue : 4 | Page : 123-129
The effect of concurrent endurance and resistance training on cardio-respiratory capacity and cardiovascular risk markers among sedentary overweight or obese post-menopausal women
Anahita Shabani1, Ramin Shabani2, Setila Dalili3, Afagh Hassanzadeh Rad3
1 Student Research Committee, Faculty of Medicine, Guilan University of Medical Science, Rasht, Iran
2 Physical Education and Sport Sciences Department, Faculty of Humanities, Rasht Branch, Islamic Azad University, Rasht, Iran
3 Department of Pediatrics, Pediatrics Growth Disorders Research Center, Medical School, 17th Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran
|Date of Submission||28-Sep-2018|
|Date of Acceptance||09-Nov-2018|
|Date of Web Publication||15-Jan-2019|
Dr. Ramin Shabani
Taleshan Bridge, Rasht Branch, Islamic Azad University, Rasht
Source of Support: None, Conflict of Interest: None
Context: Exercise training has been inversely associated with cardiovascular risk factors. However, the clinical trials examining the effect of exercise training on reducing cardiovascular risk factors have produced conflicting results.
Aims: We aimed to assess the effect of concurrent exercise training on cardiorespiratory capacity and cardio-vascular risk factors among sedentary overweight or obese post-menopausal women.
Settings and Design: This randomized controlled trial was done in 2016.
Materials and Methods: This study was conducted on 22 healthy post-menopausal overweight and obese females, which randomly divided into concurrent endurance and resistance (ER) exercise (n = 12) and control (n = 10) groups. The participants did not have any history of any serious medical condition or using drugs. Demographic questionnaire was completed, vital signs and biochemical tests were measured, and Rockport one-mile submaximal exercise test for assessing maximal oxygen consumption (VO2max) was performed before and after the study.
Statistical Analysis Used: Mean, standard deviation, and paired and independent t-test were used for statistical analysis.
Results: The data from the ER groups showed that the body mass index (BMI), heart rate (HR), systolic and diastolic blood pressure, triglyceride, high-sensitivity C-reactive protein (CRP) decreased, high-density lipoprotein, and VO2max increased significantly, during the 8 weeks (P < 0.05). Moreover, no changes were found in the cardiovascular risk factors of women who did not exercise (P > 0.05).
Conclusion: Concurrent ER training can be a suitable exercise program for improving plasma lipid profile as well as reducing body composition, high-sensitivity CRP, and increasing VO2max in postmenopausal women.
Keywords: Body composition, Cardiovascular system, Exercise training, Menopause
|How to cite this article:|
Shabani A, Shabani R, Dalili S, Hassanzadeh Rad A. The effect of concurrent endurance and resistance training on cardio-respiratory capacity and cardiovascular risk markers among sedentary overweight or obese post-menopausal women. J Nurs Midwifery Sci 2018;5:123-9
|How to cite this URL:|
Shabani A, Shabani R, Dalili S, Hassanzadeh Rad A. The effect of concurrent endurance and resistance training on cardio-respiratory capacity and cardiovascular risk markers among sedentary overweight or obese post-menopausal women. J Nurs Midwifery Sci [serial online] 2018 [cited 2021 Aug 4];5:123-9. Available from: https://www.jnmsjournal.org/text.asp?2018/5/4/123/250206
| Introduction|| |
Cardiovascular disease (CVD) is the most leading cause of mortality, complications, and disability in worldwide and Iran. Recent report of the World Health Organization in 2011 mentioned that annually 17.3 million deaths were attributed to CVD, and it will be raised up to 23.6 million deaths by 2030. Although sex differences had no significant impact on the death rate consequent to heart disease, worse complications have been noted by females with heart diseases than males that may be due to some female-specific risk factors, i.e., pregnancy, menopause, and polycystic ovarian syndrome. Furthermore, incidence of CVD is higher in women aged more than 55 years old than younger women.,, Framingham CVD risk score and Reynolds score are the first-line clinical methods in asymptomatic adults. They both evaluate several biomarkers including total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), hemoglobin A1c, and/or high-sensitivity C-reactive protein (Hs-CRP). They had been noted that significant changes in these biomarkers were commonly observed long before the occurrence of overt clinical symptoms or a cardiovascular attack. Therefore, monitoring these measurable markers during the latent phase can decrease the risk of further pathologies and complications, and prevention by reducing the risk factors of CVD is commonly recommended. Menopause can also significantly increase the risk of CVD, as a result of physiological aspects as well as physical inactivity and insufficient diet.
Postmenopausal women can reduce or control their whole and central adiposity by aerobic exercise.,, The risk of CVD can be decreased consequent to the improvements in cardiorespiratory fitness. It is noted that vascular aging can be combated by regular exercise as a therapeutic strategy. Furthermore, it is reported that exercise is an effective action in improving maximal oxygen consumption (VO2max) and HDL levels and reducing the level of plasma TG., However, it is not a sufficient method for preservation and maintenance of fat-free mass. Furthermore, resistance training can improve muscle mass and strength, but, in turn, its effectiveness in the reduction of body fat is unclear. Although the effect of aerobic or resistance training alone was assessed previously,,,, three is a limited investigation which assessed the combination of concurrent resistance and endurance training in menopause women. We aimed to examine the effect of concurrent endurance and resistance (ER) training on cardiorespiratory capacity and cardiovascular risk factory among sedentary overweight or obese postmenopausal women.
| Materials and Methods|| |
Study design and participants
This study was a randomized controlled trial, conducted in 2016 in Rasht, Iran. The study participants were sedentary overweight or obese (body mass index [BMI] ≥25 kg/m2) females (n = 24) aged 50–60 years. The entry criteria were lack of participation in any regular physical activity (regular physical activity is at least 30 min of moderate activity for 5-days per week), no history of drug use, and no history of any serious medical conditions including stroke, heart attack, and arthritis. Exclusion criteria were lack of participation in more than three sessions of program or being injured during exercise. Among 38 menopause women who met the criteria, 24 entered voluntarily in the study. Twenty-four overweight and obese postmenopausal women were randomly divided into exercise (n = 12) and control (n = 12) groups, using simple randomization. Ethical approval was obtained from the Ethical Committee of Islamic Azad University, Rasht Branch, and has been registered on the Iranian Clinical Trials Registry (IRCT2015122222498N5). Written informed consents were obtained from all participants.
The primary outcome of this research was defined as change in body composition, lipid profile, and inflammatory factor, and the secondary outcome was defined as change in VO2max. A demographic form consisting of questions about age, sex, location, job status, education status, past medical history, drug history, and smoking was completed by all of the participants at the beginning of the study. Wall stadiometer (Seca, Hamburg, Germany) and scale measured height (cm) and weight (kg), respectively, and BMI was measured as weight (kg) divided by height (m2). A flexible tape meter measured waist circumference at the maximal narrowing of the waist from the anterior view. At the point of the maximal gluteal protuberance, the hip circumference was measured from the lateral view and the waist/hip ratio (WHR) was calculated. Systolic and diastolic blood pressure (SBP and DBP) and heart rate (HR) were measured using a validated automated oscillometric cuff (Rossmax Medical, Cincinnati, USA). Double blood pressures were measured and mean was assessed. If the results differed more than 5 mmHg, a third measurement was obtained. The average of the two closest values (within 5 mmHg) was averaged and analyzed.
Cardiorespiratory capacity (maximal oxygen consumption or VO2max) was calculated as a measure of aerobic endurance. Rockport one-mile submaximal exercise test, which has been proven to be a reliable and valid protocol in predicting VO2max in untrained participants, was performed. The reliability coefficients of Rockport test is more than 0.66 and its validity coefficient is more than 0.68.
In addition, the Rockport one-mile submaximal test lessens problems of exhaustion and injuries associated with exercise testing. Maximal oxygen uptake scores were predicted from the Rockport one-mile walking test formula: VO2max = 132.853− (0.0769 × body mass) − (0.3877 × age) + (6.315 × gender) − (3.2649 × time) − (0.1565 × HR). The procedure of the test started with a warm-up of about 8–10 min. The participants' postexercise HR and times to complete the one-mile distance were recorded using a polar HR monitor.
A blood sample was drawn after a 12-h fasting period. Serum lipid profiles (total cholesterol, TG, LDL-C, and HDL-C), Hs-CRP, and blood glucose were measured at baseline and at week 8 and compared. LDL-C and HDL-C were measured directly with commercially available kits (Pishtazteb, Tehran, Iran) by immunoturbidimetry methods. Serum TG was analyzed using a total glycerol test kit (BioSystems, Barcelona, Spain) by full automation glycerol phosphate oxidase/peroxidase/endpoint methods. Serum cholesterol was analyzed using a total cholesterol test kit (BioSystems, Barcelona, Spain) by full automation cholesterol phosphate oxidase/peroxidase/endpoint methods. Serum glucose was analyzed using a total glucose test kit (BioSystems, Spain) by full automation glucose oxidase/peroxidase/endpoint methods. Hs-CRP was examined through a turbidimetric method (BioSystems Kit, Spain). All measurements were carried out on a Hitachi 747 autoanalyzer (Hitachi Ltd., Tokyo, Japan). All of the variables were measured at the beginning of trial and week 8, in both exercise group and control group, by one of the researchers. If the participants had not the psychological readiness for field tests such as Rockport one-mile walking test, the test was postponing to another day.
The exercise group underwent 8 weeks of intervention. Control group maintained their common level of activity during the trial period. The progressive concurrent exercise training programs were 8 weeks, three times per week for 90 min per se ssion, 35 min of strength training with weights of 50%–75% of one-repetition maximum (1RM), and 40 min of endurance training with an intensity of 50%–80% exercise target HR (THR) was calculated using the Karvonen equation (Target Heart Rate = ((Maximum Heart Rate − Resting Heart Rate) x %Intensity) + Resting Heart Rate). The workouts included 5–10 min warm-up and cooling. Endurance exercises such as running on a treadmill or pedaling on a bicycle ergometer were noted intermittently for 6 weeks at 50%–70% of THR. Then, the intensity was increased to 70%–80% of THR. The resistance exercise protocol aimed to work out major muscle groups of the lower and upper limbs for 35 min and involved the following exercises: chest press, knee extension, hamstrings curl, leg press, hip abduction, seated row, shoulder abduction, and plantar flexion. Intensity of resistance exercise was initially set at 50% of the predetermined 1RM test of muscular strength for 1 week and then was increased 10% every 2 weeks to a maximum of 80% of the 1RM. The 1RM measurement was done using the Brzycki 1RM prediction equation. To warm up before the test, participants performed two series with light loads for each exercise and then the resistance was increased in order to meet the requirement of 1RM measurement using the Brzycki 1RM prediction equation 1RM = (100 × W)/(102.78 – [2.78 × R]), where W = weight used (in kg) and R = maximal number of repetitions performed which can be used only if 9 or less repetitions can be completed.
Data were reported by mean and standard deviation. The normality of distribution was assessed by the Shapiro–Wilk test. Paired t-test was used for comparing quantitative parameters in intervention group before and after the 8 weeks of exercise training. Furthermore, differences in clinical parameters between the two groups (exercise vs. control group) were analyzed using independent t-test. P < 0.05 indicated statistical significance and 95% confidence interval was noted. SPSS version 22.0 (Statistical Package for Social Science, SPSS Inc., Chicago, IL, USA) was used for all the statistical analyses.
| Results|| |
The results are based on ten females in the control (56.90 ± 4.93 years old) and twelve females in the combined ER group (54.83 ± 4.72 years old). Two females in control groups did not participate in posttests due to illness. Independent t-test did not show any significant differences between two group characteristics, i.e., weight, BMI, WHR, VO2max, HR, BP, cholesterol, TG, HDL, LDL, fasting blood sugar (FBS), and CRP at the beginning of the trial [Table 1]. The effects of 8 weeks combined ER training program on body composition indices, VO2max, rest HR, and blood pressure were shown in [Table 1]. The paired t-test which assessed ER group before and after of intervention showed decreased weight, BMI and WHR, HR rest, SBP and DBP (P < 0.05), and increased VO2max significantly (P = 0.001). However, in the control group, there was a significant increase in BMI and HR rest after experimental period. On the other hand, the independent t-test showed a significant difference between control and intervention groups regarding all the above variables.
|Table 1: Body composition indices, maximum oxygen consumption, rest heart rate, and blood pressure, plasma lipid profile, blood sugar, and high-sensitivity C-reactive protein pre- and post-8 weeks of exercise training in the exercise and control groups|
Click here to view
In the intervention group, triglyceride, Hs-CRP, and LDL-to-HDL ratio were significantly decreased (P = 0.001). These women also had increased HDL by an average of 2.9% (P = 0.001) during experimental period. However, no significant change was noted based on cholesterol, LDL, and FBS. Moreover, no changes were found in the cardiometabolic risk factors of control group. The independent t-test conducted on groups showed that the TG, HDL, LDL-to-HDL ratio, and Hs-CRP levels were significantly changed during the 8-week intervention (P = 0.001). However, it was not significantly different between the two groups in the pre- and posttest exercise of cholesterol, FBS, and LDL. Correlation between cardiorespiratory capacity and TG (r = 0.76, P = 0.001), cardiorespiratory capacity and HDL-C (r = 0.60, significant = 0.003), and cardiorespiratory capacity with LDL/HDL ratio (r = 0.63, significant = 0.002) had shown in [Figure 1], [Figure 2], [Figure 3], respectively.
|Figure 1: There was a negative correlation between cardio-respiratory capacity and triglyceride|
Click here to view
|Figure 2: There was a positive correlation between cardio-respiratory capacity and high-density lipoprotein cholesterol|
Click here to view
|Figure 3: The improvement in cardiorespiratory capacity was significantly associated with decreased in low-density lipoprotein/high-density lipoprotein ratio|
Click here to view
| Discussion|| |
This study was conducted to examine the effects of 8 weeks of concurrent exercise training on cardiovascular risk factor among sedentary overweight or obese postmenopausal women. Woman transition during menopause induces irreversible complications. Menopause induces a 60% increase in the risk of developing metabolic syndrome independent of age, BMI, and physical activity. Our results showed that an 8-week ER exercise produced positive, significant reduction in several body composition and made a significant increase in VO2max. In postmenopausal women, 6%–7% weight loss presented mainly by combination of endurance and strength training and resulted in a more favorable body composition and better physical fitness. A modest body weight reduction of 3%–5% has been shown to result in clinical improvements in health. The degree of weight loss was directly related to health benefits regarding cardiovascular outcomes. On the other hand, many studies showed that exercise training could improve HR variability., Our study showed a significant increase in HDL levels and decrease in TG after 8 weeks of ER training. In contrast, some studies had demonstrated that exercise training did not improve HDL and TG significantly., This contrast might be due to the type, duration, and intensity of different exercise programs. Menopause causes an imbalance of the autonomic nervous control of the cardiovascular system that shifts toward sympathetic vagal hyperactivity and sympathetic activities in the postmenopausal group which were lower and higher than those of the premenopausal group, respectively. Postmenopausal women have lower VO2max and a greater risk of CVD compared to premenopausal women. Sedentary lifestyle and reduced cardiorespiratory fitness (peak oxygen consumption [VO2peak]) were associated with an increased cardiac sympathetic stimulation, hypertension, and/or obesity. They played a critical role in the onset and/or progression of CVD (mainly coronary heart disease), especially in postmenopausal women. The significant increase in VO2peak was consistent with previously observed aerobic training effects on postmenopausal women.
Our study showed that eight-week supervised ER training significantly improved some of the metabolic markers consist of HDL-C, LDL-to-HDL ratio and plasma TG but had no significant effect on cholesterol, LDL-C, and blood sugar in post-menopausal women. The combined training in obese postmenopausal women after the training program made a reduction in the percentage of body fat. HDL-C levels increased in the combined group, and the cholesterol/HDL ratio (atherogenic index) decreased in the aerobic group. Some studies showed increases of plasma HDL-C levels after menopause in Korean and Iranian population., Exercise which induced weight loss could similarly improve lipid profiles but with the added benefit of reducing serum TG. The findings of the current study are limited due to its small sample size. Another limitation of this study was the lack of controlling their diet lack of control on psychological parameters that can effect on field tests. Most of the studies work on endurance exercises while we worked on the impact of the simulation of resistant and endurance exercises because resistance exercises can have a significant effect on cardiovascular risk factors and strengthen type 2 muscles. Further trials are needed to corroborate our findings about the optimal dose and type of exercise required to lower CRP, cholesterol, LDL-C levels, and their effects on levels of body fatness and fitness.
| Conclusion|| |
The results of the current study indicated that Hs-CRP had a significant decrease after 8 weeks of combined training in menopause women. These results suggested that engaging in exercise training is associated with a decrease in Hs-CRP levels. In conclusion, based on the results obtained in this study, an 8-week concurrent ER exercise training could improve some plasma lipid profiles as well as a reduction in body composition, cardiorespiratory endurance (measured with VO2max), and decreased Hs-CRP. In other words, exercise training programs were effective for improving body composition and inducing an antiatherogenic status. These findings suggested that exercise training is a necessary component of lifestyle modification in obese postmenopausal women.
All authors contributed to this research.
Financial support and sponsorship
We are sincerely and heartily grateful to the participants contributing to this study. We also would like appreciate “Rasht Branch, Islamic Azad University” for their support.
| References|| |
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease study 2013. Lancet 2015;385:117-71.
Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: A population based survey. BMC Cardiovasc Disord 2007;7:32.
Smith SC Jr., Collins A, Ferrari R, Holmes DR Jr., Logstrup S, McGhie DV, et al.
Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). Eur Heart J 2012;33:2910-6.
Tu JV, Nardi L, Fang J, Liu J, Khalid L, Johansen H, et al.
National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009;180:E118-25.
Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 2015;241:211-8.
Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al.
Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-7.
Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The reynolds risk score. JAMA 2007;297:611-9.
Schisterman EF, Mumford SL, Sjaarda LA. Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women. Epidemiol Rev 2014;36:71-82.
Mendis S. The contribution of the Framingham heart study to the prevention of cardiovascular disease: A global perspective. Prog Cardiovasc Dis 2010;53:10-4.
Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: The study of women's health across the nation. Arch Intern Med 2008;168:1568-75.
Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: An update. Cardiovasc Res 2007;73:326-40.
Yassine HN, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP, et al.
Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults – A randomized clinical trial. J Gerontol A Biol Sci Med Sci 2009;64:90-5.
Choquette S, Riesco É, Cormier É, Dion T, Aubertin-Leheudre M, Dionne IJ, et al.
Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: A 6-month double-blind controlled trial. Br J Nutr 2011;105:1199-209.
Friedenreich CM, Woolcott CG, McTiernan A, Terry T, Brant R, Ballard-Barbash R, et al.
Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: A randomized controlled trial. Int J Obes (Lond) 2011;35:427-35.
Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: A randomized controlled trial. JAMA 2007;297:2081-91.
Seals DR, Walker AE, Pierce GL, Lesniewski LA. Habitual exercise and vascular ageing. J Physiol 2009;587:5541-9.
Prestes J, Shiguemoto G, Botero JP, Frollini A, Dias R, Leite R, et al.
Effects of resistance training on resistin, leptin, cytokines, and muscle force in elderly post-menopausal women. J Sports Sci 2009;27:1607-15.
Schwingshackl L, Dias S, Strasser B, Hoffmann G. Impact of different training modalities on anthropometric and metabolic characteristics in overweight/obese subjects: A systematic review and network meta-analysis. PLoS One 2013;8:e82853.
Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, et al.
Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1094-105.
Bouchard DR, Soucy L, Sénéchal M, Dionne IJ, Brochu M. Impact of resistance training with or without caloric restriction on physical capacity in obese older women. Menopause 2009;16:66-72.
Banitalebi E, Bovirhasani Baghanari H. Effect of Sequence Order of Combined Training (Resistance and Endurance) on Strength, Aerobic Capacity, and Body Composition in Older Women. Middle East J Rehabil Health Stud 2015;2:e28514.
Chau J, Chey T, Burks-Young S, Engelen L, Bauman A. Trends in prevalence of leisure time physical activity and inactivity: Results from Australian National Health Surveys 1989 to 2011. Aust N Z J Public Health 2017;41:617-24.
Fenstermaker KL, Plowman SA, Looney MA. Validation of the rockport fitness walking test in females 65 years and older. Res Q Exerc Sport 1992;63:322-7.
Brown AG, Hudson LB, Chui K, Metayer N, Lebron-Torres N, Seguin RA, et al.
Improving heart health among black/African American women using civic engagement: A pilot study. BMC Public Health 2017;17:112.
Kline GM, Porcari JP, Hintermeister R, Fredson PS, Ward A, McCarron RF, et al
. Estimation of VO2max from a one mile track walk, gender, age and body composition. Med Sci Sport Exerc. 1987;19:253-9.
Ferguson B. ACSM's guidelines for exercise testing and prescription 9th
ed. 2014. J Can Chiropr Assoc 2014;58:328-31.
Parai M, Shenoy PD, Velayutham S, Seng CK, Yee CYF. Isometric muscle strength as a predictor of one repetition maximum in healthy adult females: A crossover trial. Clin Trials Orthop Disord 2016;1:71. [Full text]
Abdul-Hameed U, Rangra P, Shareef MY, Hussain ME. Reliability of 1-repetition maximum estimation for upper and lower body muscular strength measurement in untrained middle aged type 2 diabetic patients. Asian J Sports Med 2012;3:267-73.
Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009;5:553-8.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, et al.
The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
van Gemert WA, Schuit AJ, van der Palen J, May AM, Iestra JA, Wittink H, et al.
Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: The SHAPE-2 trial. Breast Cancer Res 2015;17:120.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al
. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol 2014;63:2985-3023.
Neves VF, Silva de Sá MF, Gallo L Jr., Catai AM, Martins LE, Crescêncio JC, et al.
Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy. Braz J Med Biol Res 2007;40:491-9.
Harvey PJ, O'Donnell E, Picton P, Morris BL, Notarius CF, Floras JS, et al.
After-exercise heart rate variability is attenuated in postmenopausal women and unaffected by estrogen therapy. Menopause 2016;23:390-5.
Guadalupe-Grau A, Fernández-Elías VE, Ortega JF, Dela F, Helge JW, Mora-Rodriguez R, et al.
Effects of 6-month aerobic interval training on skeletal muscle metabolism in middle-aged metabolic syndrome patients. Scand J Med Sci Sports 2018;28:585-95.
Ho BH, Lim I, Tian R, Tan F, Aziz AR. Effects of a novel exercise training protocol of wingate-based sprint bouts dispersed over a day on selected cardiometabolic health markers in sedentary females: A pilot study. BMJ Open Sport Exerc Med 2018;4:e000349.
van Gemert WA, May AM, Schuit AJ, Oosterhof BY, Peeters PH, Monninkhof EM, et al.
Effect of weight loss with or without exercise on inflammatory markers and adipokines in postmenopausal women: The SHAPE-2 trial, A randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2016;25:799-806.
Pal GK, Pal P, Nanda N, Amudharaj D, Karthik S. Spectral analysis of heart rate variability (HRV) may predict the future development of essential hypertension. Med Hypotheses 2009;72:183-5.
Myette-Côté É, Archambault-Therrien C, Brochu M, Dionne IJ, Riesco E. Physical fitness improvement in overweight postmenopausal women who do not lose fat mass in response to exercise training. Menopause 2016;23:1122-9.
Rossi FE, Fortaleza AC, Neves LM, Buonani C, Picolo MR, Diniz TA, et al.
Combined training (Aerobic plus strength) potentiates a reduction in body fat but demonstrates no difference on the lipid profile in postmenopausal women when compared with aerobic training with a similar training load. J Strength Cond Res 2016;30:226-34.
Kim CJ, Kim TH, Ryu WS, Ryoo UH. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci 2000;15:380-6.
Azizi F, Ainy E. Coronary heart disease risk factors and menopause: A study in 1980 Tehranian women, the Tehran lipid and glucose study. Climacteric 2003;6:330-6.
Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for Overweight or Obesity. Cochrane Database of Systematic Reviews 2006;(4), Art No. CD003817.
[Figure 1], [Figure 2], [Figure 3]